SCG Cell Therapy goal is to prevent and treat cancer by using the immune system of the patient to target pathogenic infections.
SCG Cell Therapy has raised $8.1M in total funding. The most recent round was Series C. The last funding was announced in April 2023.
SCG Cell Therapy's investors include Smartech Investment Holdings.
SCG Cell Therapy is headquartered in Singapore, Singapore.
SCG Cell Therapy goal is to prevent and treat cancer by using the immune system of the patient to target pathogenic infections.
SCG Cell Therapy is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SCG Cell Therapy — Funding & Investors." VCBacked, April 5, 2023, https://www.vcbacked.co/company/scg-cell-therapy. Accessed September 15, 2026.
VCBacked. (2023). SCG Cell Therapy — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/scg-cell-therapy
{{cite web |title=SCG Cell Therapy — Funding & Investors |url=https://www.vcbacked.co/company/scg-cell-therapy |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated